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We have analyzed antibody reactivity to a fibronectin-binding microbial surface component that recognizes
adhesive matrix molecules (MSCRAMM) in blood plasma collected from patients with staphylococcal infec-
tions. All patients had elevated levels of anti-MSCRAMM antibodies compared to those of young children who,
presumably, had not been exposed to staphylococcal infections. The anti-MSCRAMM antibodies preferentially
reacted with the ligand-binding repeat domain of the adhesin. However, these antibodies did not inhibit fibro-
nectin binding. Essentially, all patients had antibodies which specifically recognized the fibronectin-MSCRAMM
complex but not the isolated components. Epitopes recognized by these anti-ligand-induced binding sites anti-
bodies were found in each repeat unit of the MSCRAMM. These results demonstrate that staphylococci have
bound fibronectin some time during infection and that each repeat unit in the MSCRAMM can engage in
ligand binding. Furthermore, our previously proposed model, suggesting that an unordered structure in the
MSCRAMM undergoes a conformational change upon ligand binding (K. House-Pompeo, Y. Xu, D. Joh, P. Spe-
ziale, and M. Ho¨o¨k, J. Biol. Chem. 271:1379–1384, 1996), is presumably operational in patients during infections.
Adherence to host tissues is the initial critical step in the
pathogenic process of most bacterial infections. Tissue adher-
ence is mediated by bacterial surface components called ad-
hesins, which recognize target ligands on host cells or in the
extracellular matrix. Because of the importance of host tissue
adherence in the pathogenic process, bacteria have adopted
strategies to secure adhesion steps and to protect adhesins
against attacks by the host defense system. Adhesins on bac-
teria which are extracellular pathogens are particularly vulner-
able, since throughout their lives in an animal these organisms
are exposed to the host’s defense systems. We have used the
abbreviation MSCRAMM (microbial surface component rec-
ognizing adhesive matrix molecules) for the family of surface
proteins binding to extracellular matrix molecules (11, 12).
Molecular studies of MSCRAMM have revealed unexpectedly
sophisticated mechanisms of ligand interactions in which host
systems are often mimicked and great efforts are made to avoid
detection by the host’s immune system.
Fibronectin (Fn)-binding MSCRAMM are present on many
pathogenic gram-positive bacteria. To date, the sequences of
almost a dozen of these MSCRAMM have been determined
(1, 4–5, 8–10, 13–17). Most have very similar structural orga-
nizations and molecular sizes of around 100 kDa. The N ter-
minus contains a long signal sequence characteristic of many
exported proteins in gram-positive bacteria. Following is a long
stretch of unique sequence, which may be interrupted by a
30- to 35-amino-acid-(aa) repeated motif of unknown func-
tion. The primary ligand-binding domain consists of three to
six repeats of a 40- to 50-aa motif. Synthetic peptides mimick-
ing individual repeat units often bind Fn and effectively inhibit
the binding of Fn to bacteria. The ligand-binding domain is found
just outside a cell wall attachment region present in many sur-
face proteins on gram-positive bacteria. At the C terminus is a
putative transmembrane segment rich in hydrophobic residues,
followed by a short cytoplasmic domain dominated by posi-
tively charged residues. A model of an Fn-binding MSCRAMM
is presented in Fig. 1.
We recently demonstrated that the ligand-binding domains
of the Fn-binding MSCRAMM do not have an organized struc-
ture but that a conformation is induced in the repeat units on
ligand binding (6). This induced fit conformation could be de-
tected by a specific monoclonal antibody which does not react
with unoccupied MSCRAMM (16). We speculated that this in-
duced-fit mechanism of ligand binding might affect the produc-
tion of inhibiting antibodies, interfering with the Fn-MSCRAMM
interaction.
In the present study, we have examined the antibody response
and specificity to the staphylococcal Fn-binding MSCRAMM
FnbpA in patients with staphylococcal infections.
MATERIALS AND METHODS
Sera. Serum specimens from 33 individuals with staphylococcal infections
(Staphylococcus aureus) were obtained from the Ospedale di Circolo, Varese,
Italy. All sera were from patients ranging from 21 to 86 years of age, with the
majority of patients over 65 years old. Antibodies from the sera were purified by
chromatography on protein A-Sepharose (Pharmacia), and the concentration of
the purified immunoglobulin G (IgG) was quantitated by absorbance at 280 nm,
with human IgG as the standard. Control IgG was obtained from pooled sera of
healthy 2-year-old children. Analysis of IgG from individual children suggests
that children have a uniformly low reactivity to the Fn-binding protein FnbpA
from S. aureus. The patients were diagnosed with a variety of staphylococcal
infections, including sepsis, pneumonia, and peritonitis. S. aureus was the only
pathogen isolated in most cases, although some multimicrobial infections were
recorded. In general, blood samples were obtained 2 days to 3 weeks after the
original diagnoses. The histories of the patients were not available.
Isolation and labeling of ligands. Human Fn was prepared as previously
reported (18). The N-terminal Fn fragment (N29) was isolated as described
previously (6). The N29 fragment was 125I labeled with IODO-BEADS iodina-
tion reagent as recommended by the manufacturer (Pierce, Rockford, Ill.).
Recombinant proteins. Recombinant proteins were expressed from plasmids
derived from pGEX-2T (Pharmacia) or pGEX-2H (see below). The pGEX
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vectors drive the production of fusion proteins in which gluthatione S-transferase
(GST) precedes the unique polypeptide segment encoded by the inserted DNA.
The N-terminal GST carrier allows the fusion proteins to be purified by affinity
chromatography with gluthatione-coupled matrix.
DNA fragments encoding the polypeptide segments indicated in Fig. 1 were
produced by PCR and cloned into the vector as previously reported (7). Table 1
describes the oligonucleotide primers used in PCR and the vector used for clon-
ing each PCR fragment. To construct the plasmid expressing GST-UA, GST-UB,
and GST-UC, DNA amplified with the indicated primers was cloned into the
BamHI/HindIII site of the vector pGEX-2H. This vector is a modified version of
pGEX-2T in which the SmaI restriction sequence was replaced by a HindIII re-
striction sequence as follows. A double-stranded oligonucleotide fragment, 59G
GAAGCTTCC39, was blunt-end ligated to pGEX-2T digested with SmaI. The
resulting vector, named pGEX-2H, lacks the SmaI restriction sequence but
possesses a HindIII restriction sequence. Table 1 describes the oligonucleotide
primers used in PCR and the vector used for the amplified fragment.
ELISA. Igs isolated from human sera were tested for antibodies against FnbpA
recombinant proteins by enzyme-linked immunosorbent assay (ELISA). Micro-
titer wells (Costar, Cambridge, Mass.) were incubated overnight at 4°C with 100
ml of 50 mM sodium carbonate, pH 9.5, containing 10 mg of protein per ml.
Additional protein binding sites in the wells were blocked by incubation for 1 h
with 200 ml of 2% (wt/vol) bovine serum albumin (BSA) in 10 mM sodium phos-
phate, pH 7.4, containing 0.13 M NaCl (phosphate-buffered saline; PBS). The
wells were then washed five times with PBST (0.1% Tween 20 in PBS-NaCl) and
incubated with 2 mg of antibody dissolved in 100 ml of 2% BSA in PBS at 22°C.
Unbound antibody was removed by washing the wells five times with PBST.
Bound antibody was detected by incubation (1 h at 37°C) with peroxidase-
conjugated rabbit anti-human IgG (Dako, Gostrup, Denmark) diluted 1:2,000.
After being washed the conjugated enzyme was reacted with o-phenylenediamine
dihydrochloride (Sigma), and the absorbance at 492 nm was monitored with a
microplate reader (Bio-Rad).
Fn-binding assay. Binding of 125I-labeled N29 to surface-immobilized
MSCRAMM was performed on microtiter plates. Wells were coated with 100 ml
of GST-Du1234 (10 mg/ml) in 50 mM sodium carbonate, incubated overnight at
4°C, and then subjected to blocking with 200 ml of 2% (wt/vol) BSA in PBS. The
wells were subsequently incubated for 2 h at 37°C with 125I-labeled N29 (8 3 104
cpm), and after extensive washing (five times) with PBST, radioactivity associ-
ated with the wells was quantitated with a gamma counter. The binding of
125I-labeled N29 to staphylococci was quantitated as described previously (16).
FIG. 1. Schematic representation of recombinant proteins containing fragments of MSCRAMM FnbpA. All the segments were expressed in fusion with GST
carrier. Fn-binding repeat units are indicated by Du, D1, D2, D3, and D4; S, signal sequence; W, cell wall spanning region; M, membrane-spanning region.
TABLE 1. Oligonucleotide primers and vectors used in the construction of plasmids expressing recombinant Fn-binding protein fragments
Expression product (vector) Direction Primera
GST-UA (pGEX-2H) Forward 59ACGTGGATCCAATCTTAGGTACGGCATTAG39
Reverse 59ACGTAAGCTTTCTAATCTTTCCACCTTC39
GST-UB (pGEX-2H) Forward 59ACGTGGATCCACGCATGGCGTATCAACTGC39
Reverse 59ACGTAAGCTTACCATTATCCCAAGTTAAGG39
GST-UC (pGEX-2H) Forward 59ACGTGGATCCGGACATCCAGAGCAAC39
Reverse 59ACGTAAGCTTCGAATGACTGGTTACCGC39
GST-Du (pGEX-2T) Forward 59ACACATGGATCCTCAAAACATCACGCTGATG39
Reverse 59TTCAACGAATTCATGATCGCTGCTCACTGCGCC39
GST-D1 (pGEX-2T) Forward 59ATCCGGATCCGAAGGTGGCCAAAATAGCG39
Reverse 59TGCTTTGAATTCCCATGAATTTGAGGT39
GST-D2 (pGEX-2T) Forward 59TTTGATGGATCCCCTCAAATTCATGGT39
Reverse 59TGCTTAGAATTCCCGTGAATATGTGGC39
GST-D3 (pGEX-2T) Forward 59GACAGTGGATCCCATATTCACGGATTC39
Reverse 59GACCTTGAATTCGGCCGCTTACTTTTGG39
GST-D4 (pGEX-2T) Forward 59GAAGATGGATCCCCAAAAGTAAGCGGCC39
Reverse 59TCTGGTGAATTCGGCGTTGGTGGCACG39
GST-Du1234 (pGEX-2T) Forward 59ACACATGGATCCTCAAAACATCACGCTGATG39
Reverse 59TCTGGTGAATTCGGCGTTGGTGGCACG39
a Restriction endonuclease sites are underlined.
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FIG. 2. Mapping of epitopes in GST-FnbpA fusion protein derivatives. GST-FnbpA polypeptides GST-UA, GST-UB, GST-UC and GST-Du1234 (1 mg in 100 ml)
were immobilized in microtiter wells and probed with IgG preparations (2 mg in 100 ml). Bound antibody was detected as described in Materials and Methods. Pooled
sera from 2-year-old children were used as the control (p). Results are expressed as means 6 standard deviations (error bars). Each sample point was done in duplicate.
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Isolation of anti-ligand-induced binding site (LIBS) antibodies by affinity
chromatography on GST-Du1234–Sepharose. Eight milligrams of IgG isolated
from patient 5 was passed through a gelatin-Sepharose column to remove pos-
sible contaminating Fn. This material was subsequently passed through a column
(1 by 4 cm) of Sepharose 4B coupled with GST-Du1234 recombinant protein and
equilibrated with PBS-azide. The column was washed with equilibration buffer
(PBS) until a stable baseline level of absorbance at 280 nm of the column effluent
was observed (flowthrough) and then with 0.4 M NaCl in 10 mM phosphate buffer,
pH 7.4. The material which specifically bound to the column was eluted with 0.1
M glycine, pH 2.8, and the fractions were neutralized with 1 M Tris. The unad-
sorbed material and the material bound and eluted from the column were
analyzed by ELISA and by Western blot analysis and dot blot analysis.
Western blotting. FnbpA recombinant GST-Du1234 protein was run in so-
dium dodecyl sulfate (SDS)–10% polyacrylamide gel under reducing conditions
and then electroblotted onto nitrocellulose membranes (Sartorius, Gottingen,
Germany) for 2 h at 200 mA in transfer buffer (20 mM Tris-HCl, 150 mM glycine,
20% [vol/vol] methanol, pH 8.3). The membranes were then treated for 1 h with
a solution containing 5% (wt/vol) dried skim milk in TBS (20 mM Tris-HCl
containing 0.5 M NaCl, pH 7.5), washed three times for 10 min each time with
TBS, and followed by 1 h of incubation with 0.7 mg of N29 per ml in 1% milk in
TTBS (TBS containing 0.05% Tween 20). Membranes were washed and incu-
bated for 2 h with IgG (0.7 mg/ml), washed three times for 10 min each time in
TTBS, and subsequently incubated for 1 h in TTBS containing 1% milk and
5,000-fold-diluted horseradish peroxidase-conjugated rabbit anti-human IgG
(Dako). After being washed, the membrane was treated with enhanced chemi-
luminescence detection reagents (NEN, Boston, Mass.) according to the proce-
dure recommended by the manufacturer and exposed to X-ray film for 30 to 60 s.
Dot blot analysis. Affinity membranes of Immobilon AV (Millipore) were
activated in PBS for 1 min and then dried with filter paper. Recombinant GST-
Du1234 protein (100 ng) dissolved in the coupling buffer (0.5 M KH2PO4, pH 7.4)
was spotted and covalently bound to the membrane. To detect the immunoreactive
spots, the membrane was probed with antibodies in the presence and absence of
N29 and treated following the procedure described for the Western blot assay.
RESULTS
IgG reacts with the repeat domain of the Fn-binding
MSCRAMM. Different segments of the S. aureus Fn-binding
FIG. 3. Antibody preparations from patients do not inhibit Fn binding to FnbpA. (A) Cells of S. aureus Cowan 1 (108) were incubated with 125I-labeled N29 (5 3
104) in the presence of 50 mg of each IgG preparation, and the radioactivity bound to the cells was quantitated. (B) GST-Du1234 was immobilized onto microtiter wells
(1 mg/well) and probed with 8 3 104 cpm of 125I-labeled N29 in the presence of 2 mg of each IgG preparation. After being washed extensively with PBS containing
0.1% Tween 20, the plates were incubated with 200 ml of 2% SDS at 37°C for 30 min, and the radioactivity released from the wells was quantitated with a gamma
counter. Controls are reported when bacteria or GST-Du1234-coated plates were incubated without antibodies (p) or with antibodies isolated from pooled sera from
young children (pp). Data are reported as means 6 standard deviations (error bars).
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MSCRAMM were expressed as recombinant proteins and pu-
rified. The reactivity of IgG to these segments coated onto mi-
crotiter plates was subsequently examined (Fig. 2). In general,
more antibodies bound to wells coated with the ligand-binding
repeat domain GST-Du1234 than to wells coated with any oth-
er recombinant MSCRAMM domain.
Patients varied substantially in terms of IgG reactivity to the
GST-Du1234 protein. IgG from patients 20, 22, and 28 seemed
to bind to the MSCRAMM at levels that were the same or
lower than those of the control IgG isolated from young
children with no history of staphylococcal infection. On the
other hand, most of the IgG from the adults bound to the
MSCRAMM at levels significantly higher than those of the
control IgG, and patients 18 and 23 gave a 10-fold-higher
response signal. Taken together, these results suggest that pa-
tients exposed to staphylococcal infections respond by produc-
ing antibodies to the Fn-binding MSCRAMM that preferen-
tially target the ligand-binding domain of the MSCRAMM. A
sample of adult IgG preparations was analyzed for concentra-
tion-dependent binding to the immobilized GST-Du1234. In
general, a linear relationship was observed when the amount of
IgG added varied from 0 to 2 mg (data not shown). The dif-
ference in reactivities among IgG preparations, seen in Fig. 2,
is therefore a reflection of relative titers.
Adult IgG does not inhibit Fn-MSCRAMM interaction. The
ability of the isolated adult IgG to interfere with the binding of
the 125I-labeled N-terminal fragment of Fn to staphylococcal
cells or to GST-Du1234 immobilized on microtiter wells was
FIG. 4. Specific formation of LIBS epitopes induced by Fn. GST-Du1234 recombinant protein was immobilized onto microtiter wells (1 mg in 100 ml) and probed
with each IgG preparation (2 mg in 100 ml) in the presence of Fn, the N-terminal Fn fragment (N29), collagen, or fibrinogen. Binding of antibodies to the recombinant
protein in absence of ligand is also shown. Bound antibody was detected as described in Materials and Methods. Bars represent means 6 standard deviations with
duplicate testing. Controls (p) represent immobilized GST-Du1234 incubated with antibodies from young children.
FIG. 5. Screening of the whole panel of IgG preparations for anti-LIBS activity. Microtiter wells were coated with GST-Du1234 (1 mg in 100 ml) and incubated with
each IgG preparation (2 mg in 100 ml) either in the absence (h) or presence (n) of 0.5 mg of N29. Bound antibody was detected as described in Materials and Methods.
Data are expressed as means 6 standard deviations (error bars) of duplicate testing.
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analyzed. At 50 mg, none of the IgG preparations significantly
interfered with Fn binding to staphylococcal cells (Fig. 3A).
The antibody preparations at 2 mg did not significantly affect
the binding of Fn to the immobilized GST-Du1234 fusion pro-
tein either (Fig. 3B). Selected patient IgG preparations were
further examined for the presence of a low concentration of
antibodies capable of interfering with the ligand-binding activ-
ity of the MSCRAMM. Thus, increasing the added IgG from
patients 1, 2, 32, and 33 up to 10 mg had no effect on Fn binding
to the immobilized GST-Du1234 (data not shown).
Patients’ IgG contains anti-LIBS antibodies. A sample of
adult IgG preparation was examined for the presence of anti-
LIBS antibodies, which recognize epitopes formed by the bind-
ing of the ligand to the MSCRAMM (2, 3). Antibody binding
to microtiter wells coated with GST-Du1234 was enhanced by
the presence of Fn for most of the IgG preparations tested
(Fig. 4). This enhanced reactivity was specifically induced
by Fn and its N-terminal fragment N29 but not by fibrino-
gen and collagen, which are known to interact with different
MSCRAMM of staphylococci. When the whole panel of IgG
preparations was examined for its reactivity toward GST-
Du1234 in the presence or absence of N29, essentially all
preparations showed strong anti-LIBS activity (Fig. 5). The
extent of anti-LIBS reactivity varied from one IgG preparation
to another. For patient 23, the presence of Fn did not increase
the amount of antibody bound to the immobilized GST-Du1234
recombinant protein. Other IgG preparations gave a signal up to
fivefold higher in the presence of the ligand. It is noteworthy
that IgG from patients 20, 22, and 28, which gave a low signal
in the absence of Fn, seemed to have a very high proportion of
anti-LIBS antibodies. The control IgG preparation contained
very low anti-LIBS activity. Taken together, these data suggest
that most individuals with staphylococcal infections develop
anti-LIBS antibodies to the Fn-binding MSCRAMM. On the
other hand, fractionation of IgG from patient 23 on a GST-
Du1234–Sepharose column did not reveal any detectable anti-
LIBS antibodies (data not shown). This result is consistent with
the observation that the reactivity of this patient’s IgG to
GST-Du1234 was not enhanced by the presence of Fn (Fig. 5).
Anti-LIBS antibodies can be isolated. To separate the anti-
LIBS antibodies from antibodies binding to the MSCRAMM
in the absence of Fn, a selected IgG preparation from patient
5 was passed through an affinity column composed of GST-
Du1234 coupled with Sepharose. The antibodies that did not
bind to the column (flowthrough) were collected separately.
The column was washed extensively, and bound antibodies were
subsequently eluted with 0.1 M glycine, pH 2.8, and neutral-
ized. The unfractionated and fractionated antibodies were
then analyzed. By an ELISA carried out in the presence or
absence of Fn, the unfractionated antibodies gave a stronger
signal in the presence of the ligand at the different concentra-
tions of antibody tested (Fig. 6A). Antibodies bound and
eluted from the affinity matrix gave the same response regard-
less of whether Fn was present in the ELISA or not (Fig. 6C).
The flowthrough IgG preparation showed weak binding to the
immobilized MSCRAMM in the absence of Fn. When Fn was
included, a markedly stronger, concentration-dependent bind-
ing of the antibody to the MSCRAMM was noted (Fig. 6B).
Fractionation of IgG from patients 15 and 26 gave similar re-
sults. In both cases, IgG that did not bind to the GST-Du1234–
Sepharose column were highly enriched with anti-LIBS anti-
bodies (data not shown).
These results were subsequently confirmed in dot blot and
Western blot assays of IgG from patient 5 (data not shown).
Unfractionated antibody reacted with MSCRAMM in the pres-
ence and absence of Fn, although the presence of the ligand
FIG. 6. ELISA of anti-LIBS antibodies isolated by affinity chromatography
on GST-Du1234. A preparation of IgG obtained from patient 5 was fractionated
onto a GST-Du1234–Sepharose column as described in Materials and Methods.
GST-Du1234 protein was immobilized onto microtiter wells (1 mg in 100 ml) and
assayed by ELISA with increasing concentrations of IgG from the flowthrough of
the column (B) or with antibodies bound and eluted from the affinity matrix (C).
Reactivity of the unfractionated IgG preparation is shown in panel A. Assays
were carried out in the absence or presence of N29. Bound antibody was de-
tected as described in Materials and Methods.
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FIG. 7. Localization of LIBS epitopes in the individual Fn-binding motifs. The Fn-binding motifs Du, D1, D2, D3, and D4 fused to the GST carrier were
immobilized onto microtiter wells (1 mg in 100 ml) and probed with the panel of IgG preparations either in the absence (h) or presence (n) of the N-terminal fragment
(N29) of Fn. Bound antibody was detected as described in Materials and Methods.
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seemed to induce a somewhat stronger signal. The affinity-
purified antibody recognized the MSCRAMM in the process,
which was seemingly unaffected by the presence or absence
of Fn. The flowthrough IgG, on the other hand, detected the
MSCRAMM only when Fn was present in the incubation mix-
ture.
Localization of the LIBS epitopes. The Fn-binding
MSCRAMM FnbpA of S. aureus contains four repeats (Du,
D1, D2, and D3) of a ligand-binding sequence and a fifth
partial repeat, D4. All these units have been shown to bind Fn
(data not shown) and could potentially form epitopes recog-
nized by anti-LIBS antibodies. To determine to which repeat
unit(s) the LIBS antibodies were directed, we expressed the
individual units as GST fusion proteins and purified the re-
combinant proteins as described previously. The whole panel
of patient IgG preparations was screened with the individual
recombinant repeat units in the presence or absence of Fn.
ELISA (Fig. 7) demonstrated that the repeat units, Du, D1,
D2, and D3, as well as the incomplete repeat unit, D4, formed
epitopes in the presence of Fn which could be recognized by
anti-LIBS antibodies. These results confirm that all the indi-
vidual repeat units are capable of binding Fn and that this
interaction can occur in patients. Presumably, the binding of
repeat units of the MSCRAMM to Fn involves a conforma-
tional change in the MSCRAMM repeats which can be man-
ifested as an epitope recognized by an anti-LIBS antibody.
The variation in anti-LIBS antibody signals to the individual
recombinant MSCRAMM repeat units differed greatly among
different IgG preparations. In general, most IgG preparations
contained anti-LIBS antibodies which recognized epitopes
formed by the Du and D3 repeat units, whereas only occa-
sional IgG preparations contained anti-LIBS antibodies recog-
nizing the complex formed by the binding of D1, D2, or D4 to
Fn.
It is noteworthy that IgG from essentially all patients con-
tained anti-LIBS antibodies by analysis with the GST-Du1234
FIG. 8. Localization of LIBS epitopes in the subfragments of the D3 motif. Microtiter wells were coated with recombinant subfragments GST-D31–21 and
GST-D3
15–36
(1 mg in 100 ml) and incubated with IgG preparations in either the absence (h) or presence (n) of N29 (see Results). Bound antibody was detected as
described in Materials and Methods.
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fragments, whereas IgG reactivity to individual recombinant
MSCRAMM repeat units revealed a lower frequency of anti-
LIBS antibodies. This result is not surprising, since anti-LIBS
antibodies detected with the GST-Du1234 fragment should
include the combined reactivities of the anti-LIBS antibod-
ies and those of the different individual MSCRAMM repeat
units.
The D3 repeat unit contains a strong Fn-binding motif lo-
cated in the C terminus, corresponding to residues 15 to 36 of
the repeat, whereas residues 1 to 21 contain one (or two) weak-
er Fn-binding motifs (data not shown). To determine if both
motifs could contain and support the formation of epitopes
recognized by anti-LIBS antibodies, the different D3 segments
were expressed as recombinants and targeted by ELISA. The
results of this experiment showed that the C-terminal, but not
the N-terminal, motif could form epitopes recognized by anti-
LIBS antibodies (Fig. 8).
DISCUSSION
We have analyzed the immune response to the Fn-binding
MSCRAMM in patients with S. aureus infections. The patient
population was quite varied, and in this study, we did not at-
tempt to correlate the immune response to onset, type of infec-
tion, or patient group. Rather, we were interested in determin-
ing the reactivity of antibodies produced by humans in response
to staphylococcal infection. We found that antibodies purified
by affinity chromatography on a protein A-Sepharose column
bound preferentially to the Fn-binding repeat domain of the
MSCRAMM. This observation suggests that the repeat do-
main is immunodominant over other MSCRAMM domains,
a conclusion which is supported by a recent study in which
;80% of monoclonal antibodies generated from mice immu-
nized with the full-length MSCRAMM were found to be direct-
ed to the repeat domain (data not shown). Alternatively, these
observations could reflect variations in serum type. Analyses of
strain collections suggest that most S. aureus strains contain the
gene encoding the Fn-binding MSCRAMM FnbpA. However,
the sequence variability of the gene in different isolates has not
been determined. The patients from whom the IgG was de-
rived most likely were infected by strains whose Fn-binding
MSCRAMM sequences differ. The observed low IgG binding
to MSCRAMM regions outside the repeat region may simply
reflect a great sequence variability in this region among differ-
ent strains compared to a presumably conserved ligand-bind-
ing domain.
None of the IgG preparations significantly inhibited the bind-
ing of Fn to isolated recombinant MSCRAMM or to intact bac-
teria. This surprising result does not have an obvious molecular
explanation. Is it possible that the MSCRAMM binds Fn with
a much higher affinity than a competing potentially inhibiting
antibody and that consequently inhibiting antibodies are not
detected? Is the ligand-binding surface of the MSCRAMM
always occupied by Fn and therefore never detected as foreign
and a target for an immune response? The observed confor-
mational changes induced in the MSCRAMM on ligand bind-
ing could help protect the binding surface of the MSCRAMM,
since it is not formed in the absence of Fn. The presence of
anti-LIBS antibodies demonstrates that the Fn-MSCRAMM
complex is exposed to the immune system. Epitopes recog-
nized by the anti-LIBS antibodies were detected in each of the
repeat units in the ligand-binding domain when they were
presented as recombinant individual units. These observations
demonstrate that each repeat unit is capable of binding Fn and
suggest that these interactions involve conformational changes
in the MSCRAMM repeat units. Furthermore, when recom-
binant fragments of the D3 unit were examined, we found that
the C-terminal 20-amino-acid residues which contain a high-
affinity binding site also harbor a LIBS, suggesting that LIBS
can be located close to the ligand-binding surface. It is not
clear if the LIBS is formed only by residues in the MSCRAMM
or if residues in Fn can contribute to the epitope. So far, we
have not been able to demonstrate the direct binding of these
IgG preparations to Fn by ELISA. The value of LIBS antibod-
ies to the patient is not known. LIBS antibodies could be op-
sonic and stimulate phagocytic clearance of the bacteria. On
the other hand, previous studies suggest that these antibod-
ies may be advantageous to bacteria by stabilizing Fn bind-
ing and thus enhancing bacterial adherence to the host tissue
(16).
Since MSCRAMM are currently being targeted in different
bacterial vaccination strategies, further studies to determine
the significance of anti-LIBS antibodies are clearly warranted.
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